Technologies On The Shelf
The Problem The development of a biomarker for hypoxic tissues is essential both for diagnostic formulation and treatment planning for…Read More
The Problem Most optical-physiological diagnoses are based on the insertion of light, with known parameters, to a tested tissue, followed…Read More
An Interactive Gaze Contingent System for the Diagnosis and Treatment of Social Communication and Attention Deficits in Infants and Children
The Problem Over the last two decades a dramatic increase in the prevalence of socio-communicative disorders and attention disorders was…Read More
BIRAD grants exclusive and non-exclusive licenses for the commercialization of BIU-based research findings, both to established companies and to new startup ventures established around University technology.
The licenses are granted for specific patents and/or know-how and are limited to a specific field and/or specific products. Licenses include diligence milestones for the development and sale of products covered by the license – to avoid technology "shelving" – and typically include a combination of the following forms of consideration: royalties, milestone payments, upfront fees, equity and/or annual license fees.